Executive Digest

<div class="section1"><div class="Normal"><span style="" font-weight:="" bold="">Spitzer sues MonsterHut on spam charges:</span> New York attorney general Eliot Spitzer has filed a suit against marketing firm MonsterHut Inc for sending millions of unsolicited commercial e-mails, known as spam, to consumers. The suit accuses the firm, CEO Todd Pelow and CTO Gary Hartl of fraudulently advertising and representing the firm’s e-mail as “permission based.� “Permission based,� or “opt-in,� means every consumer to whom they send commercial e-mail has explicitly asked to receive it.<br /><span style="" font-weight:="" bold="">Sony, Fujitsu call off ISP tie-up talks:</span> Sony Corp said on Wednesday it and Fujitsu Ltd have called off talks on cooperation in Internet services, including its possible purchase from Fujitsu of Japan’s largest ISP.While the decision deprives Sony of a quick means to become Japan’s largest ISP, an ambition clearly laid out by its top brass, it was hardly a surprise after Sony executives complained repeatedly that the talks were hobbled by media attention. “The two could not come together on terms,� said a spokesman for Sony, the world’s largest consumer electronics maker. <br /><span style="" font-weight:="" bold="">Traffic to M&M Web site skyrockets 145%:</span> Traffic to the M&M Mars Web site skyrocketed 145 per cent earlier this month due to Internet surfers voting for the newest M&M candy colour, according to Nielsen/NetRatings. MMS.com attracted 336,000 surfers logging on at home during the week ended May 19, compared to 137,000 visitors the week prior, said Internet audience measurement service NetRatings. Purple took the top spot as the most popular colour choice. Thirty per cent of the total audience visiting the site voted for purple, 19 wanted aqua, while pink garnered 9 per cent.<br /><span style="" font-weight:="" bold="">Glaxo in new row over AIDS drug pricing:</span> GlaxoSmithKline Plc was embroiled in a fresh row over the cost of AIDS medicines after a US group barred GSK sales representatives from its clinics. </div> </div>